S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
Urgent Warning (Ad)
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
Urgent Warning (Ad)
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
Urgent Warning (Ad)
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
Urgent Warning (Ad)
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
Urgent Warning (Ad)
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
Urgent Warning (Ad)
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
Urgent Warning (Ad)
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
Urgent Warning (Ad)
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
Urgent Warning (Ad)
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
Urgent Warning (Ad)
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
Urgent Warning (Ad)
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
Urgent Warning (Ad)
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
NASDAQ:ADMP

Adamis Pharmaceuticals - ADMP Stock Forecast, Price & News

$0.12
0.00 (0.00%)
(As of 03/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$0.11
▼
$0.13
50-Day Range
$0.10
▼
$0.30
52-Week Range
$0.10
▼
$0.62
Volume
752,243 shs
Average Volume
1.35 million shs
Market Capitalization
$17.97 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

ADMP stock logo

About Adamis Pharmaceuticals (NASDAQ:ADMP) Stock

Adamis Pharmaceuticals Corp. is a biopharmaceutical company, which engages in the discovery, development, and sale of pharmaceutical, specialty biopharmaceutical, and other drug products. The company provides products in various therapeutic areas, including allergy, respiratory, opioid overdose, and erectile dysfunction markets. It offers the SYMJEPI Injection for the emergency treatment of allergic reactions. The company was founded in June 2006 and is headquartered in San Diego, CA.

Receive ADMP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Adamis Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

ADMP Stock News Headlines

March 27, 2023 | americanbankingnews.com
Adamis Pharmaceuticals (NASDAQ:ADMP) Coverage Initiated at StockNews.com
March 21, 2023 | americanbankingnews.com
StockNews.com Begins Coverage on Adamis Pharmaceuticals (NASDAQ:ADMP)
March 28, 2023 | Oxford Club (Ad)
My No. 1 dividend stock for a LIFETIME of income.
Few people realize this… But dividends account for up to 90% of the stock market's returns over the past century!  I think it's a crying shame folks don't know how powerful dividends are.
March 19, 2023 | finance.yahoo.com
Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) Q4 2022 Earnings Call Transcript
March 17, 2023 | finance.yahoo.com
Q4 2022 Adamis Pharmaceuticals Corp Earnings Call
March 16, 2023 | msn.com
Adamis Pharmaceuticals GAAP EPS of -$0.18, revenue of $4.75M
March 16, 2023 | finance.yahoo.com
Adamis Pharmaceuticals Reports Full Year 2022 Financial Results and Provides Corporate Update
March 14, 2023 | finance.yahoo.com
Adamis Pharmaceuticals Schedules Fourth Quarter and Full Year 2022 Financial Results Conference Call and Corporate Update
March 28, 2023 | Weiss Ratings (Ad)
Fed's Shocking New Plan to Control Your Money
The Federal Reserve has a disturbing plan that is getting ready to roll out as soon as May. This is a lot more than printing trillions of dollars or manipulating interest rates. It's about every checking account, every purchase and every money transfer in America — including yours and mine. 
March 14, 2023 | finance.yahoo.com
Adamis Pharmaceuticals Announces $3.0 Million Registered Direct Offering
March 2, 2023 | benzinga.com
Short Volatility Alert: Adamis Pharmaceuticals
March 1, 2023 | benzinga.com
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Adamis Pharmaceuticals Corporation Merger
February 28, 2023 | msn.com
Opioid Focused Adamis Pharma Agrees To Merge With Privately Held DMK Pharmaceuticals
February 28, 2023 | msn.com
Adamis Pharmaceuticals jumps 36% on DMK Pharmaceuticals merger plan
February 27, 2023 | finance.yahoo.com
Adamis Pharmaceuticals and DMK Pharmaceuticals Announce Agreement and Plan of Merger
February 22, 2023 | finance.yahoo.com
Nasdaq Grants Adamis Pharmaceuticals’ Request for Extension to Comply with Continued Listing Requirements
December 29, 2022 | finance.yahoo.com
Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) Q3 2022 Earnings Call Transcript
November 15, 2022 | finanznachrichten.de
Adamis Pharmaceuticals Corporation: Adamis Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
November 15, 2022 | seekingalpha.com
Adamis Pharmaceuticals Corporation (ADMP) Q3 2022 Earnings Call Transcript
November 15, 2022 | finance.yahoo.com
Adamis Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
November 12, 2022 | msn.com
A Preview Of Adamis Pharmaceuticals's Earnings
November 7, 2022 | finance.yahoo.com
Adamis Pharmaceuticals Schedules Third Quarter 2022 Financial Results Conference Call and Corporate Update
October 18, 2022 | msn.com
Why fuboTV Shares Are Trading Higher By 11%; Here Are 22 Stocks Moving Premarket
October 12, 2022 | msn.com
Why Cango Shares Are Trading Higher; Here Are 27 Stocks Moving Premarket
October 5, 2022 | marketwatch.com
Adamis Pharmaceuticals Shares Jump 14% On Potential Sale, Strategic Alternatives
October 3, 2022 | nasdaq.com
Adamis Pharma To Explore Strategic Alternatives; Stock Up 10%
October 3, 2022 | finance.yahoo.com
Adamis Announces Review of Strategic Alternatives
See More Headlines
Receive ADMP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Adamis Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

ADMP Company Calendar

Last Earnings
3/31/2022
Today
3/28/2023
Next Earnings (Estimated)
5/15/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ADMP
CUSIP
N/A
CIK
887247
Web
www.adamispharmaceuticals.com
Phone
(858) 997-2400
Fax
N/A
Employees
116
Year Founded
2006

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-26,480,000.00
Net Margins
-556.71%
Pretax Margin
-550.82%
Return on Equity
-420.53%
Return on Assets
-147.30%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.81
Quick Ratio
0.70

Sales & Book Value

Annual Sales
$4.76 million
Price / Sales
3.77
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.01) per share
Price / Book
-11.98

Miscellaneous

Outstanding Shares
149,980,000
Free Float
148,033,000
Market Cap
$17.97 million
Optionable
Optionable
Beta
1.26

Social Links


Key Executives

  • David J. Marguglio
    President, Chief Executive Officer & Director
  • David C. Benedicto
    Chief Financial Officer
  • Thomas H. Moll
    Vice President-Research
  • Robert H. Uhl
    Investor Relations Contact

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions













ADMP Stock - Frequently Asked Questions

How have ADMP shares performed in 2023?

Adamis Pharmaceuticals' stock was trading at $0.1693 on January 1st, 2023. Since then, ADMP stock has decreased by 29.2% and is now trading at $0.1198.
View the best growth stocks for 2023 here.

Are investors shorting Adamis Pharmaceuticals?

Adamis Pharmaceuticals saw a increase in short interest in March. As of March 15th, there was short interest totaling 2,000,000 shares, an increase of 28.2% from the February 28th total of 1,560,000 shares. Based on an average daily volume of 1,280,000 shares, the short-interest ratio is currently 1.6 days.
View Adamis Pharmaceuticals' Short Interest.

When is Adamis Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 15th 2023.
View our ADMP earnings forecast.

How were Adamis Pharmaceuticals' earnings last quarter?

Adamis Pharmaceuticals Co. (NASDAQ:ADMP) announced its quarterly earnings results on Thursday, March, 31st. The specialty pharmaceutical company reported ($0.06) earnings per share for the quarter, missing the consensus estimate of ($0.04) by $0.02. Adamis Pharmaceuticals had a negative trailing twelve-month return on equity of 420.53% and a negative net margin of 556.71%. During the same period in the previous year, the business posted ($0.16) EPS.

What other stocks do shareholders of Adamis Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Adamis Pharmaceuticals investors own include Trevena (TRVN), Amarin (AMRN), Sorrento Therapeutics (SRNE), Verastem (VSTM), Dynavax Technologies (DVAX), Novavax (NVAX), SCYNEXIS (SCYX), Synergy Pharmaceuticals (SGYP), Agile Therapeutics (AGRX) and OPKO Health (OPK).

What is Adamis Pharmaceuticals' stock symbol?

Adamis Pharmaceuticals trades on the NASDAQ under the ticker symbol "ADMP."

Who are Adamis Pharmaceuticals' major shareholders?

Adamis Pharmaceuticals' stock is owned by a number of institutional and retail investors. Top institutional shareholders include Geode Capital Management LLC (0.88%), Simplex Trading LLC (0.00%), HighTower Advisors LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include David C Benedicto, David J Marguglio, Dennis J Phd Carlo, Karen K Daniels, Robert O Hopkins and Ronald B Moss.
View institutional ownership trends.

How do I buy shares of Adamis Pharmaceuticals?

Shares of ADMP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Adamis Pharmaceuticals' stock price today?

One share of ADMP stock can currently be purchased for approximately $0.12.

How much money does Adamis Pharmaceuticals make?

Adamis Pharmaceuticals (NASDAQ:ADMP) has a market capitalization of $17.97 million and generates $4.76 million in revenue each year.

How many employees does Adamis Pharmaceuticals have?

The company employs 116 workers across the globe.

How can I contact Adamis Pharmaceuticals?

Adamis Pharmaceuticals' mailing address is 11682 EL CAMINO REAL SUITE 300, SAN DIEGO CA, 92130. The official website for the company is www.adamispharmaceuticals.com. The specialty pharmaceutical company can be reached via phone at (858) 997-2400 or via email at mflather@adamispharma.com.

This page (NASDAQ:ADMP) was last updated on 3/28/2023 by MarketBeat.com Staff